Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (111-120 of 385) with videos related to

Pageof 39
Sort By:
Cancers|September 9, 2022
Concomitant Cytotoxic Effector Differentiation of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells in Response to EBV-Infected B CellsYumi Tamura, Keita Yamane, Yohei Kawano, et al.
Frontiers in Immunology|April 25, 2022
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort StudyFelix Korell, Olaf Penack, Mike Mattie, et al.
Bone Marrow Transplantation|January 31, 2021
Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complicationHao Dai, Olaf Penack, Aleksandar Radujkovic, et al.
Haematologica|January 25, 2020
Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panelSihe Jiang, Olaf Penack, Tobias Terzer, et al.
Oncotarget|July 8, 2016
Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markersSonja C Lueck, Annika C Russ, Ursula Botzenhardt, et al.
Therapeutic Advances in Neurological Disorders|February 7, 2018
Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literatureJennifer Jeck, Rebecca Kassubek, Jan Coburger, et al.
Blood Advances|March 8, 2021
Deregulated expression of circular RNAs in acute myeloid leukemiaSusanne Lux, Tamara J Blätte, Bernhard Gillissen, et al.
Blood|March 1, 2008
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AMLLars Bullinger, Konstanze Döhner, Raphael Kranz, et al.
Blood|June 19, 2008
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cellsWinnie F Tam, Ting-Lei Gu, Jing Chen, et al.
BMC Genomics|September 13, 2014
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeSimone Feurstein, Frank G Rücker, Lars Bullinger, et al.
Pageof 39

Showing results (111-120 of 385) with videos related to

Sort By:
Pageof 39
Cancers|September 9, 2022
Concomitant Cytotoxic Effector Differentiation of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells in Response to EBV-Infected B CellsYumi Tamura, Keita Yamane, Yohei Kawano, et al.
Frontiers in Immunology|April 25, 2022
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort StudyFelix Korell, Olaf Penack, Mike Mattie, et al.
Bone Marrow Transplantation|January 31, 2021
Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complicationHao Dai, Olaf Penack, Aleksandar Radujkovic, et al.
Haematologica|January 25, 2020
Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panelSihe Jiang, Olaf Penack, Tobias Terzer, et al.
Oncotarget|July 8, 2016
Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markersSonja C Lueck, Annika C Russ, Ursula Botzenhardt, et al.
Therapeutic Advances in Neurological Disorders|February 7, 2018
Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literatureJennifer Jeck, Rebecca Kassubek, Jan Coburger, et al.
Blood Advances|March 8, 2021
Deregulated expression of circular RNAs in acute myeloid leukemiaSusanne Lux, Tamara J Blätte, Bernhard Gillissen, et al.
Blood|March 1, 2008
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AMLLars Bullinger, Konstanze Döhner, Raphael Kranz, et al.
Blood|June 19, 2008
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cellsWinnie F Tam, Ting-Lei Gu, Jing Chen, et al.
BMC Genomics|September 13, 2014
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeSimone Feurstein, Frank G Rücker, Lars Bullinger, et al.
Pageof 39